Hub : Traits

BMI without tail

Tags: Physiology · Weight

Project: dissection

9 loci · 14 genes with independent associations · 100 total associated genes

Significant Loci

#	Chr	Start pos	End pos	# assoc genes	# joint models	Best TWAS P	Best GWAS P	Cond GWAS P	Joint genes
1	chr1	163118025	164452706	1	1	1.11e-07	5.77e-05	1.00e+00	C1h11orf16
2	chr1	170052145	172342305	3	2	5.60e-08	5.60e-08	1.00e+00	Nucb2 Xylt1
3	chr1	257928278	260518987	22	5	1.64e-15	1.45e-15	1.00e+00	Grk5 LOC102550729 Prlhr Rab11fip2 Sfxn4
4	chr3	129554891	131114742	2	1	7.39e-08	4.76e-08	1.00e+00	Kif16b
5	chr8	95829798	97221784	1	1	1.29e-07	6.26e-05	9.16e-02	Xrn1
6	chr8	108585012	109845634	1	1	7.80e-14	1.22e-02	4.34e-02	Klhdc8b
7	chr9	12862716	16264314	66	1	1.44e-09	1.44e-09	2.20e-01	Tcte1
8	chr9	75969545	77365260	1	1	6.65e-26	5.76e-01	1.00e+00	Zfand2b
9	chr10	104672625	106124937	3	1	1.15e-07	2.87e-07	1.00e+00	Slc38a10

Pleiotropic Associations

Trait	Chi2 ratio	# genes+	# genes++	% genes++	Corr	Corr P	Genes
BMI with tail	15.52	51	18	128.6	0.93	6.63e-79	Aars2 Bicral C1h11orf16 C9h6orf132 Cacul1 Capn11 Cdc5l Ces2c Cnpy3 Cul7 Dennd10 Emx2os Fam204a Gnmt Grk5 Hsp90ab1 Kif16b Klc4 Klhdc3 Klhdc8b LOC100912427 LOC102550729 LOC681367 Mea1 Mrpl2 Mrps10 Nanos1 Nfkbie Nucb2 Otor Pex6 Ppp2r5d Prdx3 Prlhr Ptk7 Rab11fip2 Rrp36 Sfxn4 Slc29a1 Slc35b2 Spats1 Srf Tcte1 Trerf1 Ubr2 Vegfa Xrn1 Xylt1 Zfand2b Zfp318 Zfp950
Body weight	17.22	41	16	114.3	0.95	1.29e-69	Bicral C9h6orf132 Cacul1 Ces2c Cnpy3 Cul7 Dennd10 Emx2os Fam204a Gnmt Grk5 Kif16b Klc4 Klhdc3 Klhdc8b LOC100912427 LOC102550729 LOC681367 Mea1 Mrpl2 Mrps10 Nanos1 Nfkbie Nucb2 Otor Pex6 Ppp2r5d Prdx3 Prlhr Ptk7 Rab11fip2 Rrp36 Sfxn4 Slc29a1 Trerf1 Ubr2 Vegfa Xrn1 Xylt1 Zfp318 Zfp950
Epididymis fat weight	37.04	16	15	107.1	1	8.27e-82	Cacul1 Ces2c Dennd10 Emx2os Fam204a Grk5 Kif16b LOC102550729 Nanos1 Otor Prdx3 Prlhr Rab11fip2 Sfxn4 Zfand2b Zfp950
Glucose	9.83	8	0	0	1	2.38e-35	Cacul1 Ces2c Dennd10 Fam204a Grk5 LOC102550729 Sfxn4 Zfp950
Heart weight	12.26	13	1	7.1	0.82	2.00e-12	Cacul1 Ces2c Dennd10 Emx2os Fam204a Grk5 Klhdc8b LOC102550729 Prlhr Rab11fip2 Sfxn4 Zfand2b Zfp950
Left kidney weight	11.58	17	15	107.1	0.92	9.28e-33	Cacul1 Ces2c Dennd10 Emx2os Fam204a Grk5 Klhdc8b LOC102550729 Nanos1 Nucb2 Prdx3 Prlhr Rab11fip2 Sfxn4 Xylt1 Zfand2b Zfp950
Right kidney weight	11.38	17	15	107.1	0.9	9.65e-28	Cacul1 Ces2c Dennd10 Emx2os Fam204a Grk5 Klhdc8b LOC102550729 Nanos1 Nucb2 Prdx3 Prlhr Rab11fip2 Sfxn4 Xylt1 Zfand2b Zfp950
Tail length	46.46	3	1	7.1	0	1.00e+00	Klhdc8b Nucb2 Zfand2b
Length with tail	4.18	10	1	7.1	0.99	5.37e-28	Cacul1 Ces2c Dennd10 Grk5 Klhdc8b Nanos1 Prlhr Sfxn4 Zfand2b Zfp950
Length without tail	11.08	11	1	7.1	0.42	7.63e-02	Aars2 Cacul1 Emx2os Fam204a Grk5 Nfkbie Prlhr Rab11fip2 Sfxn4 Zfand2b Zfp950
Liver weight, left	9.96	9	0	0	0.76	2.81e-04	C1h11orf16 Cacul1 Dennd10 Fam204a Grk5 Klhdc8b Prlhr Rab11fip2 Sfxn4
Liver weight, right	11.74	12	6	42.9	0.99	8.55e-58	Cacul1 Ces2c Dennd10 Fam204a Grk5 LOC102550729 Nanos1 Prlhr Rab11fip2 Sfxn4 Zfand2b Zfp950
Parametrial fat weight	20.75	31	15	107.1	0.96	1.22e-58	Aars2 Cacul1 Ces2c Cnpy3 Cul7 Dennd10 Emx2os Fam204a Gnmt Grk5 Kif16b Klc4 Klhdc3 LOC102550729 Mea1 Mrpl2 Mrps10 Nanos1 Nucb2 Otor Pex6 Prdx3 Prlhr Rab11fip2 Rrp36 Sfxn4 Slc29a1 Spats1 Trerf1 Zfand2b Zfp950
Retroperitoneal fat weight	41.22	17	15	107.1	0.99	4.35e-60	Cacul1 Ces2c Dennd10 Emx2os Fam204a Grk5 Kif16b Klhdc8b LOC102550729 Nanos1 Otor Prdx3 Prlhr Rab11fip2 Sfxn4 Zfand2b Zfp950
Intraocular pressure	51.69	1	1	7.1	0	1.00e+00	Zfand2b
Extensor digitorum longus weight	3.75	3	0	0	0	1.00e+00	Emx2os Sfxn4 Xylt1
Soleus weight	5.45	6	0	0	1	2.07e-10	Ces2c Grk5 Klhdc8b Nanos1 Rab11fip2 Zfp950
Tibialis anterior weight	4.68	2	0	0	0	1.00e+00	Nucb2 Xylt1
Tibia length	10.96	1	1	7.1	0	1.00e+00	Klhdc8b
Number of licking bursts	28.51	2	2	14.3	0	1.00e+00	Klhdc8b Zfand2b
Food consumed during 24 hour testing period	15.78	1	0	0	0	1.00e+00	Zfand2b
Mean num. licks in bursts	14.92	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Std. dev. time between licks in bursts	12.12	1	0	0	0	1.00e+00	Zfand2b
Water consumed over 24 hours	34.33	1	1	7.1	0	1.00e+00	Zfand2b
Patch foraging indifference point 0 sec	10.05	2	0	0	0	1.00e+00	Emx2os Zfand2b
Patch foraging indifference point AUC	24.2	1	1	7.1	0	1.00e+00	Zfand2b
Indifference point function ln k	45.4	2	2	14.3	0	1.00e+00	Klhdc8b Zfand2b
Indifference point function log k	45.4	2	2	14.3	0	1.00e+00	Klhdc8b Zfand2b
Patch foraging total patch changes 0 sec	10.1	10	1	7.1	1	8.28e-15	Cacul1 Emx2os Fam204a Grk5 Klhdc8b Prlhr Rab11fip2 Sfxn4 Zfand2b Zfp950
Patch foraging total patch changes 18 sec	48.28	1	1	7.1	0	1.00e+00	Zfand2b
Patch foraging total patch changes 24 sec	77.61	1	1	7.1	0	1.00e+00	Zfand2b
Patch foraging total patch changes 6 sec	13.28	4	1	7.1	0.97	2.94e-02	Emx2os Prlhr Rab11fip2 Zfand2b
Patch foraging time to switch 0 sec	15.3	4	1	7.1	1	1.09e-03	Klhdc3 LOC681367 Rrp36 Zfand2b
Patch foraging water rate 0 sec	23.88	2	1	7.1	0	1.00e+00	Klhdc3 Zfand2b
Patch foraging water rate 12 sec	69.49	1	1	7.1	0	1.00e+00	Zfand2b
Patch foraging water rate 24 sec	12.61	1	0	0	0	1.00e+00	Zfand2b
Patch foraging water rate 6 sec	35.43	1	1	7.1	0	1.00e+00	Zfand2b
Locomotor activity	35.08	2	1	7.1	0	1.00e+00	Klhdc8b Zfand2b
Locomotor testing distance	55.86	2	2	14.3	0	1.00e+00	Klhdc8b Zfand2b
Locomotor testing rearing	99.51	1	1	7.1	0	1.00e+00	Zfand2b
Light reinforcement 1	19.25	1	1	7.1	0	1.00e+00	Zfand2b
Reaction time number correct	66.72	2	2	14.3	0	1.00e+00	Klhdc8b Zfand2b
Reaction time mean minus median	98.07	2	1	7.1	0	1.00e+00	C1h11orf16 Zfand2b
Reaction time mean minus median AUC	122.84	2	1	7.1	0	1.00e+00	C1h11orf16 Zfand2b
Reaction time num false alarms AUC	27.43	1	1	7.1	0	1.00e+00	Zfand2b
Reaction time trials correct on left	66.72	2	2	14.3	0	1.00e+00	Klhdc8b Zfand2b
Reaction time trials on left	63.1	2	2	14.3	0	1.00e+00	Klhdc8b Zfand2b
Reaction time mean	36.11	1	1	7.1	0	1.00e+00	Zfand2b
Reaction time mean AUC	33.75	1	1	7.1	0	1.00e+00	Zfand2b
Median of all reaction times	14.09	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Reaction time omissions	35.15	2	2	14.3	0	1.00e+00	Klhdc8b Zfand2b
Reaction time false alarm rate	20.24	1	1	7.1	0	1.00e+00	Klhdc8b
Reaction time premature initiations	41.6	1	1	7.1	0	1.00e+00	Zfand2b
Std. dev. reaction times	42.37	2	1	7.1	0	1.00e+00	C1h11orf16 Zfand2b
Reaction time trials completed	63.1	2	2	14.3	0	1.00e+00	Klhdc8b Zfand2b
Reaction time trials AUC	64.7	2	2	14.3	0	1.00e+00	Klhdc8b Zfand2b
Conditioned locomotion	28.4	1	1	7.1	0	1.00e+00	Klhdc8b
Cocaine response after cond. corrected	12.71	1	0	0	0	1.00e+00	Zfand2b
Cocaine response after cond. not corrected	16.6	1	0	0	0	1.00e+00	Klhdc8b
Cocaine response before conditioning	38.66	1	1	7.1	0	1.00e+00	Klhdc8b
Pavlov. Cond. magazine entry number	30	1	1	7.1	0	1.00e+00	Klhdc8b
Conditioned reinforcement - actives	152.54	1	1	7.1	0	1.00e+00	Zfand2b
Conditioned reinforcement - inactives	76.2	2	1	7.1	0	1.00e+00	Klhdc8b Zfand2b
Conditioned locomotion	13.93	1	0	0	0	1.00e+00	Zfand2b
Intermittent access intake day 1-15 change	156.77	1	1	7.1	0	1.00e+00	Zfand2b
Intermittent access intake escalation	117.41	1	1	7.1	0	1.00e+00	Zfand2b
Intermittent access intake escalation 2	17.78	1	0	0	0	1.00e+00	C1h11orf16
Intermitt. access day 1 inactive lever presses	91.66	2	1	7.1	0	1.00e+00	Klhdc8b Zfand2b
Intermitt. access day 15 inactive lever presses	162.52	2	2	14.3	0	1.00e+00	Klhdc8b Zfand2b
Intermittent access day 1 total infusions	71.42	1	1	7.1	0	1.00e+00	Zfand2b
Intermittent access day 15 total infusions	24.8	2	1	7.1	0	1.00e+00	Klhdc8b Zfand2b
Intermittent access terminal intake (last 3 days)	24.92	2	1	7.1	0	1.00e+00	Klhdc8b Zfand2b
Intermittent access total infusions	15.45	1	0	0	0	1.00e+00	Klhdc8b
Intermittent access day 1 locomotion	26.47	1	1	7.1	0	1.00e+00	Zfand2b
Intermittent access day 15 total locomotion	93.08	1	1	7.1	0	1.00e+00	Zfand2b
Intermittent access total locomotion	12.43	1	0	0	0	1.00e+00	Zfand2b
Intermittent access standard deviation	229.66	2	1	7.1	0	1.00e+00	Klhdc8b Zfand2b
Cocaine induced anxiety	69.5	2	1	7.1	0	1.00e+00	Klhdc8b Zfand2b
Baseline Anxiety	393.92	1	1	7.1	0	1.00e+00	Zfand2b
Incentive Sensitization - Responses	309.83	1	1	7.1	0	1.00e+00	Zfand2b
Incentive Sensitization - Breakpoint	300.45	1	1	7.1	0	1.00e+00	Zfand2b
Progressive ratio test 1 active lever presses	26.41	1	1	7.1	0	1.00e+00	Zfand2b
Progressive ratio test 1 breakpoint	19.19	1	0	0	0	1.00e+00	Zfand2b
Progressive ratio test 1 inactive lever presses	16.55	1	0	0	0	1.00e+00	Klhdc8b
Progressive ratio test 2 active lever presses	109.22	1	1	7.1	0	1.00e+00	Zfand2b
Progressive ratio test 2 breakpoint	106.65	1	1	7.1	0	1.00e+00	Zfand2b
Progressive ratio test 2 inactive lever presses	63.47	1	1	7.1	0	1.00e+00	Zfand2b
Total sessions with >9 infusions	15.19	2	0	0	0	1.00e+00	C1h11orf16 Klhdc8b
Short access day 1 total inactive lever presses	17.49	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Short access day 10 total inactive lever presses	72.35	2	2	14.3	0	1.00e+00	Klhdc8b Zfand2b
Short access day 10 total infusions	13.17	1	0	0	0	1.00e+00	Klhdc8b
Short access day 1 locomotion	129.19	1	1	7.1	0	1.00e+00	Zfand2b
Short access day 10 total locomotion	432.47	1	1	7.1	0	1.00e+00	Zfand2b
Short access total locomotion	209.96	1	1	7.1	0	1.00e+00	Zfand2b
Compulsive drug intake	68.39	1	1	7.1	0	1.00e+00	Zfand2b
One hour access (0.3 mA shock)	18.01	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Number of responses in last shaping day	67.75	1	1	7.1	0	1.00e+00	Zfand2b
Locomotion distance, session 1	23.98	1	1	7.1	0	1.00e+00	Klhdc8b
Locomotion velocity, session 2	14.35	1	0	0	0	1.00e+00	Trerf1
Locomotion distance, session 2	33.15	1	1	7.1	0	1.00e+00	Klhdc8b
Locomotion velocity, session 3	17.14	1	0	0	0	1.00e+00	Klhdc8b
Locomotion distance, session 3	14.51	1	0	0	0	1.00e+00	Klhdc8b
Locomotion distance, session 8	52.78	1	1	7.1	0	1.00e+00	Klhdc8b
Degree of sensitization distance	24.75	1	0	0	0	1.00e+00	Klhdc8b
Condit. Reinf. active minus inactive responses	35.59	1	1	7.1	0	1.00e+00	Klhdc8b
Condit. Reinf. active-inactive response ratio	25.6	1	1	7.1	0	1.00e+00	Klhdc8b
Condit. Reinf. active responses	18.23	1	0	0	0	1.00e+00	Klhdc8b
Incentive salience index mean	26.23	1	1	7.1	0	1.00e+00	Klhdc8b
Condit. Reinf. lever presses	10.81	1	0	0	0	1.00e+00	Klhdc8b
Time in familiar zone, hab. session 1	63.49	1	1	7.1	0	1.00e+00	Klhdc8b
Total zone transitions, hab. session 1	37.38	1	1	7.1	0	1.00e+00	Klhdc8b
Total locomotion distance, hab. session 1	10.76	1	0	0	0	1.00e+00	Klhdc8b
Locomotion velocity, hab. session 1	10.22	1	0	0	0	1.00e+00	Klhdc8b
Time in familiar zone, hab. session 2	27.1	1	1	7.1	0	1.00e+00	Klhdc8b
Total zone transitions, hab. session 2	69.58	1	1	7.1	0	1.00e+00	Klhdc8b
Total locomotion distance, hab. session 2	19.2	1	0	0	0	1.00e+00	Klhdc8b
Locomotion velocity, hab. session 2	21.15	1	1	7.1	0	1.00e+00	Klhdc8b
Novel to familiar place preference ratio	22.33	1	0	0	0	1.00e+00	Klhdc8b
Novelty place preference	20.99	1	0	0	0	1.00e+00	Klhdc8b
Time in novel zone, NPP test	17.06	1	0	0	0	1.00e+00	Klhdc8b
Total zone transitions, NPP test	41.93	3	1	7.1	0	1.00e+00	Klhdc3 Klhdc8b Rrp36
Total locomotion distance, NPP test	28.8	2	1	7.1	0	1.00e+00	Klhdc8b Xrn1
Locomotion velocity, NPP test	51.12	1	1	7.1	0	1.00e+00	Klhdc8b
Pavlov. Cond. change in total contacts	69.48	1	1	7.1	0	1.00e+00	Klhdc8b
Pavlov. Cond. index score	14.07	1	0	0	0	1.00e+00	Klhdc8b
Pavlov. Cond. magazine entry number	12.23	1	0	0	0	1.00e+00	Klhdc8b
Pavlov. Cond. lever-magazine prob. diff.	14.82	1	0	0	0	1.00e+00	Klhdc8b
Bone: apparent density	8.24	1	0	0	0	1.00e+00	Cacul1
Bone volume	9.37	5	0	0	1	1.18e-12	Cacul1 Grk5 Prlhr Rab11fip2 Sfxn4
Bone: cortical apparent density	11.41	4	0	0	-1	1.27e-05	C1h11orf16 Cacul1 Dennd10 Sfxn4
Bone: cortical area	13.06	12	0	0	1	3.63e-83	Cacul1 Ces2c Dennd10 Emx2os Fam204a Grk5 LOC102550729 Nanos1 Prlhr Rab11fip2 Sfxn4 Zfp950
Bone: cortical thickness	9.98	9	0	0	0.99	3.07e-17	Cacul1 Ces2c Emx2os Fam204a Grk5 Prlhr Rab11fip2 Sfxn4 Zfp950
Bone: cortical thickness	12.52	1	0	0	0	1.00e+00	Grk5
Bone: cortical tissue density	11.17	6	0	0	-0.99	5.25e-23	C1h11orf16 Cacul1 Ces2c Dennd10 Grk5 Sfxn4
Bone: final force	9.51	12	0	0	1	2.29e-53	Cacul1 Ces2c Dennd10 Emx2os Fam204a Grk5 LOC102550729 Nanos1 Prlhr Rab11fip2 Sfxn4 Zfp950
Bone: final moment	9.93	12	0	0	1	7.37e-60	Cacul1 Ces2c Dennd10 Emx2os Fam204a Grk5 LOC102550729 Nanos1 Prlhr Rab11fip2 Sfxn4 Zfp950
Bone: maximum diameter	8.17	5	0	0	1	7.21e-19	Cacul1 Dennd10 Grk5 Prlhr Sfxn4
Bone: maximum force	9.46	9	0	0	0.99	1.98e-24	Cacul1 Emx2os Fam204a Grk5 Nanos1 Prlhr Rab11fip2 Sfxn4 Zfp950
Bone: maximum moment	9.73	10	0	0	1	1.86e-26	Cacul1 Dennd10 Emx2os Fam204a Grk5 Nanos1 Prlhr Rab11fip2 Sfxn4 Zfp950
Bone: minimum diameter	7.55	9	0	0	1	1.51e-43	Cacul1 Ces2c Dennd10 Emx2os Grk5 LOC102550729 Prlhr Sfxn4 Zfp950
Bone: periosteal estimation	8.51	12	0	0	1	1.04e-77	Cacul1 Ces2c Dennd10 Emx2os Fam204a Grk5 LOC102550729 Nanos1 Prlhr Rab11fip2 Sfxn4 Zfp950
Bone: periosteal perimeter	11.13	12	0	0	1	6.20e-64	Cacul1 Ces2c Dennd10 Emx2os Fam204a Grk5 LOC102550729 Nanos1 Prlhr Rab11fip2 Sfxn4 Zfp950
Bone: stiffness	13.41	1	0	0	0	1.00e+00	Klhdc8b
Bone: tissue strength	14.55	1	0	0	0	1.00e+00	C1h11orf16
Bone: trabecular number	11.4	1	0	0	0	1.00e+00	C1h11orf16
Bone: trabecular spacing	15.64	1	0	0	0	1.00e+00	C1h11orf16
Bone: trabecular thickness	13.35	11	0	0	1	1.67e-66	Cacul1 Ces2c Dennd10 Emx2os Fam204a Grk5 LOC102550729 Prlhr Rab11fip2 Sfxn4 Zfp950
Breakpoint value in progressive ratio session	15.73	1	0	0	0	1.00e+00	Nucb2
Distance traveled before self-admin	17.44	1	0	0	0	1.00e+00	C1h11orf16
Delta time in open arm before/after self-admin	26.67	1	0	0	0	1.00e+00	Zfand2b
Active lever presses in extinction session 6	26.41	1	0	0	0	1.00e+00	Zfand2b
Time in closed arm before self-admin	44.32	1	1	7.1	0	1.00e+00	Zfand2b
Time in open arm before self-admin	24.67	1	0	0	0	1.00e+00	Zfand2b
Time to tail flick, vehicle, after self-admin	56.6	2	2	14.3	0	1.00e+00	Klhdc8b Zfand2b
Delta time to tail flick, vehicle, before/after SA	44.54	2	1	7.1	0	1.00e+00	Klhdc8b Zfand2b
Ambulatory time before self-admin	20.51	2	0	0	0	1.00e+00	C1h11orf16 Zfand2b
Total heroin consumption	18.89	1	0	0	0	1.00e+00	Klhdc8b
Area under the delay curve	31.15	1	1	7.1	0	1.00e+00	Zfand2b
Delay disc. indifference point, 0s delay	28.7	1	1	7.1	0	1.00e+00	Klhdc8b
Delay disc. indifference point, 16s delay	21.3	4	1	7.1	-1	1.31e-07	Cnpy3 Rrp36 Trerf1 Zfand2b
Delay disc. indifference point, 24s delay	27.43	1	0	0	0	1.00e+00	Zfand2b
Delay disc. indifference point, 4s delay	41.82	1	1	7.1	0	1.00e+00	Klhdc8b
Delay disc. indifference point, 8s delay	74.24	1	1	7.1	0	1.00e+00	Zfand2b
Delay discount exponential model param	16.14	1	0	0	0	1.00e+00	Zfand2b
Delay discount hyperbolic model param	15.89	1	0	0	0	1.00e+00	Zfand2b
Fecal boli incidents, locomotor time 1	96.73	2	1	7.1	0	1.00e+00	Klhdc8b Zfand2b
Time >=10cm from walls, locomotor time 1	79.04	1	1	7.1	0	1.00e+00	Zfand2b
Rest time, locomotor task time 1	20.01	2	0	0	0	1.00e+00	Klhdc8b Nucb2
Distance moved, locomotor task time 1	31.01	1	1	7.1	0	1.00e+00	Klhdc8b
Vertical activity count, locomotor time 1	73.36	2	2	14.3	0	1.00e+00	Klhdc8b Zfand2b
Bouts of movement, locomotor time 2	21.88	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Total resting periods, locomotor time 2	28.25	2	1	7.1	0	1.00e+00	Klhdc8b Zfand2b
Rest time, locomotor task time 2	35.13	2	2	14.3	0	1.00e+00	Klhdc8b Zfand2b
Distance moved, locomotor task time 2	63.13	2	2	14.3	0	1.00e+00	Klhdc8b Zfand2b
Vertical activity count, locomotor time 2	34.04	2	1	7.1	0	1.00e+00	Klhdc8b Zfand2b
Weight adjusted by age	30.32	1	1	7.1	0	1.00e+00	Klhdc8b
Seeking ratio, delayed vs. immediate footshock	12.86	5	0	0	-0.99	1.78e-07	C1h11orf16 Ces2c Fam204a Grk5 Sfxn4
Locomotion in novel chamber post-restriction	13.43	2	0	0	0	1.00e+00	C1h11orf16 Zfand2b
Food seeking constrained by brief footshock	13.85	2	0	0	0	1.00e+00	Klhdc8b Zfand2b
Run reversals in cocaine runway, females	36.45	1	1	7.1	0	1.00e+00	Zfand2b
Latency to leave start box in cocaine runway	34.23	1	1	7.1	0	1.00e+00	Zfand2b
Latency to leave start box in cocaine runway, F	31.9	1	1	7.1	0	1.00e+00	Zfand2b
Latency to leave start box in cocaine runway, M	55.97	1	1	7.1	0	1.00e+00	C1h11orf16
Cd content in liver	20.17	1	0	0	0	1.00e+00	Klhdc8b
Fe content in liver	40.39	1	1	7.1	0	1.00e+00	Klhdc8b
Mg content in liver	15.79	1	0	0	0	1.00e+00	Klhdc8b
Mn content in liver	12.13	1	0	0	0	1.00e+00	C1h11orf16
Na content in liver	16.36	1	0	0	0	1.00e+00	Klhdc8b
Rb content in liver	51.88	1	1	7.1	0	1.00e+00	Klhdc8b
Sr content in liver	22.41	1	0	0	0	1.00e+00	Klhdc8b
Zn content in liver	14.97	1	0	0	0	1.00e+00	C1h11orf16

Associations by panel

Tissue	RNA modality	# hits	% hits/tests	Avg chisq
Adipose	alternative polyA	4	0.1	2.05
Adipose	alternative TSS	0	0	2.07
Adipose	gene expression	16	0.2	2.05
Adipose	isoform ratio	1	0	1.97
Adipose	intron excision ratio	0	0	1.97
Adipose	mRNA stability	0	0	2.01
BLA	alternative polyA	1	0	1.96
BLA	alternative TSS	2	0.1	2.12
BLA	gene expression	7	0.1	2.09
BLA	isoform ratio	1	0	2.07
BLA	intron excision ratio	1	0	2.03
BLA	mRNA stability	5	0.2	2.1
Brain	alternative polyA	5	0.1	1.97
Brain	alternative TSS	2	0	2.12
Brain	gene expression	14	0.1	2.05
Brain	isoform ratio	5	0.1	2.07
Brain	intron excision ratio	4	0.1	2.03
Brain	mRNA stability	3	0.1	1.99
Eye	alternative polyA	1	0.3	2.39
Eye	alternative TSS	0	0	2.1
Eye	gene expression	0	0	1.98
Eye	isoform ratio	0	0	2.08
Eye	intron excision ratio	0	0	2.27
Eye	mRNA stability	0	0	2.32
IL	alternative polyA	1	0.1	2.15
IL	alternative TSS	0	0	2.05
IL	gene expression	3	0.1	2.06
IL	isoform ratio	1	0.1	2.05
IL	intron excision ratio	2	0.2	2.31
IL	mRNA stability	2	0.1	2.17
LHb	alternative polyA	0	0	2.17
LHb	alternative TSS	0	0	1.96
LHb	gene expression	3	0.1	2.04
LHb	isoform ratio	2	0.2	2.13
LHb	intron excision ratio	0	0	2.13
LHb	mRNA stability	1	0.1	1.99
Liver	alternative polyA	1	0	2.1
Liver	alternative TSS	4	0.2	2.03
Liver	gene expression	13	0.2	2.06
Liver	isoform ratio	6	0.2	2.09
Liver	intron excision ratio	3	0.1	1.98
Liver	mRNA stability	3	0.1	2.05
NAcc	alternative polyA	2	0.1	2.09
NAcc	alternative TSS	0	0	2.09
NAcc	gene expression	9	0.1	2.09
NAcc	isoform ratio	5	0.1	2.13
NAcc	intron excision ratio	3	0.1	2.12
NAcc	mRNA stability	7	0.2	2.09
OFC	alternative polyA	0	0	2.07
OFC	alternative TSS	2	0.3	2.47
OFC	gene expression	3	0.1	2.1
OFC	isoform ratio	0	0	2.04
OFC	intron excision ratio	0	0	2.38
OFC	mRNA stability	1	0.1	2.15
PL	alternative polyA	6	0.2	1.98
PL	alternative TSS	2	0.1	2.12
PL	gene expression	9	0.1	2.08
PL	isoform ratio	1	0	2.08
PL	intron excision ratio	4	0.1	2.21
PL	mRNA stability	3	0.1	2.06
pVTA	alternative polyA	0	0	2.06
pVTA	alternative TSS	0	0	2.13
pVTA	gene expression	8	0.2	2.12
pVTA	isoform ratio	3	0.1	2.08
pVTA	intron excision ratio	0	0	2.05
pVTA	mRNA stability	1	0.1	2
RMTg	alternative polyA	0	0	1.75
RMTg	alternative TSS	0	0	2.12
RMTg	gene expression	4	0.2	2.08
RMTg	isoform ratio	0	0	1.92
RMTg	intron excision ratio	0	0	2.09
RMTg	mRNA stability	0	0	1.98